Report 27.12.2024
Jūnijs - decembris 2024
Sniegta palīdzība 30 906,46 eiro apmērā 12 onkoloģijas pacientiem:
Reģistrācijas nr. | Sūtītājs | Rēķina nr. | Izraktīšanas datums | Summa | Palīdzības veids |
6.3/2024/3468 | Insbergs SIA | DZ 2862 | 05.12.2024 | 500,97 € | Medikamenti |
6.3/2024/3055 | GENEKOR, SIA | PRF0000091 | 31.10.2024. | 3 000,00 € | Oncotype DX Breast Cancer assay-Invasive tests |
6.3/2024/3054 | GENEKOR, SIA | PRF0000090 | 31.10.2024. | 3 000,00 € | Oncotype DX Breast Cancer assay-Invasive tests |
6.3/2024/3048 | Saules aptieka, SIA | SA240073 | 28.10.2024 | 705,49 € | Medikamenti |
6.3/2024/2675 | GENEKOR, SIA | Oncotype DX Breast Cancer assay-Invasive_BLT | 19.09.2024 | 3 000,00 € | Oncotype DX Breast Cancer assay-Invasive tests |
6.3/2024/2674 | GENEKOR, SIA | PRF0000085 | 19.09.2024 | 3 000,00 € | Oncotype DX Breast Cancer assay-Invasive tests |
6.3/2024/2672 | GENEKOR, SIA | PRF0000084 | 19.09.2024 | 3 000,00 € | Oncotype DX Breast Cancer assay-Invasive tests |
6.3/2024/1858 | E. Gulbja laboratorija | 9768435 (23214-ZIED) | 30.06.2024 | 2 700,00 € | Vēža gēnu karte |
6.3/2024/1853 | GENEKOR, SIA | PRF0000063 | 01.07.2024 | 3 000,00 € | Oncotype DX Breast Cancer assay-Invasive tests |
6.3/2024/1718 | GENEKOR, SIA | PRF0000061 | 17.06.2024 | 3 000,00 € | Oncotype DX Breast Cancer assay-Invasive tests |
6.3/2024/1717 | GENEKOR, SIA | PRF0000059 | 17.06.2024 | 3 000,00 € | Oncotype DX Breast Cancer assay-Invasive tests |
6.3/2024/1568 | GENEKOR, SIA | PRF0000057 | 03.06.2024 | 3 000,00 € | Oncotype DX Breast Cancer assay-Invasive tests |